Acelyrin, Inc.
SLRN
$2.69
-$0.06-2.18%
| Weiss Ratings | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 7.60% | |||
| 30-Day Total Return | 40.84% | |||
| 60-Day Total Return | -24.01% | |||
| 90-Day Total Return | -54.41% | |||
| Year to Date Total Return | -18.48% | |||
| 1-Year Total Return | -67.35% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -67.99% | |||
| 52-Week Low % Change | 49.05% | |||
| Price | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.59 | |||
| 52-Week Low Price | $1.85 | |||
| 52-Week Low Price (Date) | Feb 11, 2025 | |||
| 52-Week High Price (Date) | Mar 20, 2024 | |||
| Valuation | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 276.93M | |||
| Enterprise Value | -278.06M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.68 | |||
| Earnings Per Share Growth | -86.54% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.52 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $2.69 | |||
| Enterprise Value/EBITDA (TTM) | 0.85 | |||
| Enterprise Value/EBIT | 0.84 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 99.84M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 805 730 0360 | |||
| Address | 4149 Liberty Canyon Road Agoura Hills, CA 91301 | |||
| Website | www.acelyrin.com | |||
| Country | United States | |||
| Year Founded | 2020 | |||
| Profitability | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -29.01% | |||
| Return on Equity | -- | |||
| Income Statement | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -328.92M | |||
| EBIT (TTM) | -329.25M | |||
| Net Income (TTM) | -264.41M | |||
| Net Income Avl. to Common (TTM) | -264.41M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 42.16% | |||
| EPS Diluted (TTM) | -2.68 | |||
| EPS Diluted Growth (Q YOY) | 43.88% | |||
| Balance Sheet | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 562.37M | |||
| Cash Per Share (Q) | $5.63 | |||
| Total Current Assets (Q) | 596.59M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 528.28M | |||
| Current Ratio (Q) | 7.147 | |||
| Book Value Per Share (Q) | $5.29 | |||
| Total Assets (Q) | 618.31M | |||
| Total Current Liabilities (Q) | 83.47M | |||
| Total Debt (Q) | 7.38M | |||
| Total Liabilities (Q) | 90.03M | |||
| Total Common Equity (Q) | 528.28M | |||
| Cash Flow | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 84.98M | |||
| Cash from Financing (TTM) | 6.12M | |||
| Net Change in Cash (TTM) | -164.87M | |||
| Levered Free Cash Flow (TTM) | -165.01M | |||
| Cash from Operations (TTM) | -255.97M | |||
